期刊文献+

不同淋巴细胞亚群NKg2D的表达与结肠癌发病关系的研究 被引量:3

Correlation between Expression of NKg2D on lymphocytes and the Development of Colon Cancer
下载PDF
导出
摘要 目的探讨不同淋巴细胞亚群表面NKg2D受体的表达与结肠癌发病的关系。方法首先收集10例结肠癌组织、外周血及相应肿瘤组织引流淋巴结和11例正常个体的外周血,分别用免疫组化检测肿瘤组织内NKg2D阳性淋巴细胞的数目,用流式细胞仪检测外周血及引流淋巴结内NKg2D阳性的总淋巴细胞数、CD8+T细胞数、γδT细胞数及NK细胞数。结果结肠癌肿瘤组织内无NKg2D阳性的淋巴细胞,患者外周血NKg2D+NK细胞与正常个体相比明显减少(P=0.03),发生肿瘤转移的淋巴结内总淋巴细胞NKg2D的表达与同一个体外周血的相比,迅速降低(P=0.006),而且转移淋巴结内NKg2D+γδT细胞也明显减少(P=0.049)。结论结肠癌细胞可通过抑制NKg2D的表达而减弱机体的免疫功能。 Objective To study the correlation between the expression of NKg2D and the development of colon cancer. Methods We analyzed the expression of NKg2D on 10 primal tumor tissues, peripheral blood and 10 drained lymph nodes of colon cancer patients and 11 peripheral blood samples from healthy controls, NKg2D positive cells in tumor tissues were detected by the method of immunochemistry, The percentage of NKg2D positive cells in total lymphocytes, CD8^+ T cells, γδT cells and NK cells were observed by flow cytometry. Results We didn't observe the expression of NKg2D on lymphocytes in primal cancer cells, the percentage of NKg2D and CD56 double positive cells in patients was significantly lower than that in healthy controls, The expression of NKg2D on lymphocytes from lymph nodes with metastasis decreased dramatically compared with corresponding peripheral blood lymphocytes, especially the expression of NKg2D onγδT cells, Conclusion Our results suggested that cancer cell may acquire evasion from immune surveillance through decreasing the expression of NKg2D. In addition, monitoring the expression of NKG2D on peripheral lymphocytes may not be a sensitive biomarker for evaluation the metastasis of tumor to lymph nodes.
出处 《实用临床医药杂志》 CAS 2008年第1期47-50,共4页 Journal of Clinical Medicine in Practice
基金 国家自然科学基金资助项目(30400399) 扬州大学科研基金资助项目(PK0313100)
关键词 NKG2D 结肠癌 表达 NKg2D colon cancer expression
  • 相关文献

参考文献10

  • 1龚卫娟.MICA基因研究进展[J].国外医学(遗传学分册),2001,24(4):184-188. 被引量:14
  • 2刘丹,季明春.NK细胞表面活化性受体的研究进展[J].国际免疫学杂志,2006,29(5):302-305. 被引量:6
  • 3Watzl C. The NKG2D receptor and its ligands-recognition beyond the “missing self” [J]. Microbes Infect, 2003, 5: 31.
  • 4Groh V, Wu J, Yee C, et al. Tumor-derived soluble MIC ligands impair expression of NKG2D and T-cell activation [J]. Nature, 2002, 419: 734.
  • 5Doubrovina E S, Doubrovin M M, Vider E, et al. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenoearcinoma[J]. J Immunol, 2003, 171: 6891.
  • 6Salih H R, Rammensee H G, Steinle A. down-regulation of MICA on human tumors by proteolytic shedding [J ]. J Immunol, 2002, 169: 4098.
  • 7Lee J C, Lee K M, Kim D W, et al. Elevated TGF-βI secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients [ J ]. J Immunol, 2004, 172: 7335.
  • 8Oppenheim D E, Roberts S J, Clarke S L, et al. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxiclty in vivo and reduces tumor immunosurveillance[J]. Natur Immunology, 2004, 6: 928.
  • 9Coudert J D, Zimmer J, Tomasello E, et al. Altered NKG2D function in NK cells induced by chronic expo sure to NKG2D ligand-expressing tumor cells [ J ]. Blood, 2005, 106: 1711.
  • 10Bahram S, Inoko H, Shinno T, et al. MICA and other NKG2D ligands: from none to many[J ]. Curr Opin Immunol, 2005, 17: 505.

二级参考文献24

  • 1郭忠慧.-[J].中华风湿病学杂志,1999,3:4-7.
  • 2Campbell KS,Yusa S,Kikuchi-Maki A,et al.NKp44 triggers NK cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequence.J Immunol,2004,172 (2):899-906.
  • 3Costello RT,Sivori S,Marcenaro E,et al.Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia.Blood,2002,99 (10):3661-3667.
  • 4Mavoungou E,Bouyou-Akotet MK,Kremsner PG,et al.Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46,NKp44 and NKp30).J Immunol,2005,139 (2):287-296.
  • 5Nowbakht P,Rohner A,Rossy E,et al.Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias.Blood,2005,105 (9):3615-3622.
  • 6Bloushtain N,Qimron U,Bar-Ilan A,et al.Membrane-Associated Heparan Sulfate Proteoglycans Are Involved in the Recognition of Cellular Targets by NKp30 and NKp46.J Immunology,2004,173 (4):2392-2401.
  • 7Carrington M,Wang S,Martin1 MP,et al.Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulinlike receptor and human leukocyte antigen loci.J Exp Med,2005,201(7):1069-1075.
  • 8George WN,Maureen PM,Gladman D,et al.Heterozygote Advantage in Autoimmune Disease:Hierarchy of Protection/Susceptibility Conferred by HLA and Killer Ig-Like Receptor Combinations in Psoriatic Arthritis.J Immunol,2004,173 (7):4273-4276.
  • 9Yen JH,Moore BE,Nakajima T,et al.Major Histocompatibility Complex Class I-recognizing Receptors Are Disease Risk Genes in Rheumatoid Arthritis.J Exp Med,2001,193 (10):1159-1167.
  • 10Momot T,Koch S,Hunzelmann N,et al.Association of killer cell immunoglobulin-like receptors with scleroderma.Arthritis Rheum,2004,50 (5):1561-1565.

共引文献18

同被引文献48

  • 1杨林,刘映霞.肝细胞癌NKG2D表达及对NK细胞细胞毒的影响[J].医学临床研究,2004,21(5):475-477. 被引量:5
  • 2Salih HR, Antropius H, Gieseke F, et al. Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia [J]. Blood, 2005, 102(4) : 1389 -1396.
  • 3Jinushi M, Hodl FS, Dranoff G. Therapies - induced antibodies to MHC class Ⅰ chain - related protein A antagonize immune suppression and stimulate antitumor cytotoxicity [ J]. PNAS, 2006, 103 (6) : 9190 -9195.
  • 4Oppenheim DE, Roberts SJ, Clarke SL, et al. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance [J]. Nat Immunol, 2004, 6(9): 928-937.
  • 5Gasser S, Raulet DH. The DNA damage response arouses the immune system [J]. Cancer Res, 2006, 66 (8) : 3959 -3962.
  • 6Groh V, Wu J, Yee C, et al. Tumor - derived soluble MIC li - gands impair expression of NKG2D and T - cell activation [J]. Nature, 2002, 419 (9) : 734 -738.
  • 7Wu JD, Higgins LM, Steinle A, et al. Prevalent expression of the immunostimulatory MHC class Ⅰ chain - related molecule is counteracted by shedding in prostate cancer [ J]. J Clin Invest, 2004, 114(4) : 560-568.
  • 8Doubrovina ES, Doubrovin MM, Vider E, et al. Evasion from NK cell immunity by MHC class Ⅰ chain - related molecules expressing colon adenocarcinoma. [ J ]. J Immunol, 2003, 171 (12) : 6891 - 6899.
  • 9Jumnainsong A, Romphruk AV, Jearanaikoon P, et al. Association of polymorphic extracellular domains of MICA with cervical cancer in northeastern Thai population [ J ]. Tissue Antigens, 2007, 69(4) : 326- 333.
  • 10Tamaki S, Sanefuzi N, Kawakami M, et al. Association between soluble MICA levels and disease stage Ⅳ oral squamous cell carcinoma in Japanese patients [J]. Hum Immonol, 2008, 69(2) :88 -93.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部